3 hours Guardant Health (NASDAQ:GH) Price Target Cut to $50.00MarketBeat
Leerink Partners decreased their price objective on Guardant Health from $60.00 to $50.00 and set an “outperform” rating on the stock in a research note on Thursday.
Health · Nasdaq 100 · Science
X